Standard Biotools is trading at $0.73, up +5.10% on September 16, 2026, alongside a constructive broader market backdrop.
- The Nasdaq rose 0.64%, while the S&P 500 gained 0.36%.
- No new company-specific announcement was identified; volume was 841.06K shares versus a 1.91M average, suggesting below-average activity.
- The anticipated 25-basis-point Fed hike and ongoing merger-related background remain relevant context, but neither was newly reported.